Objectives. The prevalence of interstitial lung disease (ILD) in RA is ∼5%. Previous work
identified increasing age, active articular disease and articular damage as risk factors for RA-…

INTRODUCTION: An increased prevalence of musculoskeletal disease is recognised in
diabetes and is a common source of disability. It is known to predominantly affect the upper …

Coronavirus disease 2019 (COVID-19) is a novel systemic disease that affects multiple organs,
with the lungs being most affected. 1-3 Previous studies have demonstrated that carbon …

Recent findings have highlighted the potential initiation of ACPA in sites away from the joint.
Periodontitis is an example of this concept. This process in the gums appears to be …

Objective This study explores whether the prognosis of interstitial lung disease in rheumatoid
arthritis (RA-ILD) has improved over time and assesses the potential influence of drug …

Objective To determine whether intensive combinations of synthetic disease modifying drugs
can achieve similar clinical benefits at lower costs to high cost biologics such as tumour …

Rheumatoid arthritis (RA) is associated with a ten-fold increased risk of interstitial lung disease
(ILD). The presence of ILD in a patient with RA influences both prognosis and the choice …

The modified early warning score (MEWS) was developed as a track and trigger tool for the
prompt identification of seriously ill patients on an acute medical ward. This paper examines …

Objective To analyze the efficacy and safety of nintedanib in patients with fibrosing autoimmune
disease–related interstitial lung diseases (ILDs) with a progressive phenotype. Methods …

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting 0.5–1% of the worldwide
population. Whilst predominantly causing chronic pain and inflammation in synovial joints…